TABLE 1.
Clinical characteristics of BAL donors
| COVID‐19 | Healthy controls | |
|---|---|---|
| N | 33 | 25 |
| Women/Men | 16/17 | 16/9 |
| Smoker (Y/N) | 5/28 | 0/25 |
| Death (Y/N) | 2/31 | N/A |
| SARS‐CoV‐2 detection in BAL (Ct) | 25 ± 1 | N/A |
| Age | 58 ± 3 | 26 ± 1 |
| Weight (kg) | 73 ± 3 | N/A |
| Hospital stay (days) | 21 ± 2 | N/A |
| Days before BAL | 3 ± 1 | N/A |
| D‐Dimers (mg/mL) | 1.21 ± 0.13 | N/A |
| CRP (mg/l) | 20.65 ± 2.53 | N/A |
| ALT (U/l) | 32.6 ± 2.1 | N/A |
| AST (U/l) | 35.1 ± 3.0 | N/A |
| LDH (U/l) | 616 ± 41 | N/A |
| Hemoglobin (g/l) | 123 ± 2 | N/A |
| Blood Monocytes (million/mL) | 0.3 ± 0.03 | N/A |
| Blood Neutrophils (million/mL) | 2.9 ± 0.19 | N/A |
| Blood Eosinophils (million/mL) | 0.03 ± 0.003 | N/A |
| Blood Platelets (million/mL) | 182 ± 13 | N/A |
| Blood Lymphocytes (million/mL) | 1.13 ± 0.13 | N/A |
| Platelet to Lymphocyte ratio (PLR) | 223.89 ± 34.93 | N/A |
| BAL Neutrophils (million/mL) | 24.7 ± 2.2 | 0.001 ± 0.0002 |
| BAL Eosinophils (million/mL) | 0.2 ± 0.08 | 0.000 ± 0.000 |
| BAL Lymphocytes (million/mL) | 21.8 ± 2.4 | 0.004 ± 0.001 |
| BAL macrophages (million/mL) | N/A | 0.073 ± 0.007 |
Data are presented as the mean ±SEM.
Abbreviations: ALT, alanine transaminase; AST, aspartate transaminase; CRP, C‐reactive protein; LDH, Lactate dehydrogenase; N/A, not available.
This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.